Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 1 | uM | 4 | 1250.00 | 814.29 | 996.00 | 1704.50 | 0.5843 | 0.2081 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1776.00 | 1704.50 | 1.0419 | 1.0786 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1998.00 | 1704.50 | 1.1722 | 1.3215 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1631.00 | 1704.50 | 0.9569 | 0.9190 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 1250.00 | 814.29 | 1723.00 | 1704.50 | 1.0109 | 1.0204 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1572.00 | 1704.50 | 0.9223 | 0.8538 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1935.00 | 1704.50 | 1.1352 | 1.2528 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 1250.00 | 814.29 | 1597.00 | 1704.50 | 0.9369 | 0.8814 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1518.00 | 1704.50 | 0.8906 | 0.7939 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1692.00 | 1704.50 | 0.9927 | 0.9862 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1652.00 | 1704.50 | 0.9692 | 0.9421 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1354.00 | 1704.50 | 0.7944 | 0.6115 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1486.00 | 1704.50 | 0.8718 | 0.7584 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 1250.00 | 814.29 | 1632.00 | 1704.50 | 0.9575 | 0.9201 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1374.00 | 1704.50 | 0.8061 | 0.6338 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 1250.00 | 814.29 | 1605.00 | 1704.50 | 0.9416 | 0.8903 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1467.00 | 1704.50 | 0.8607 | 0.7373 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1792.00 | 1704.50 | 1.0513 | 1.0962 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1589.00 | 1704.50 | 0.9322 | 0.8726 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1279.00 | 1704.50 | 0.7504 | 0.5276 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1515.00 | 1704.50 | 0.8888 | 0.7906 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 1250.00 | 814.29 | 1401.00 | 1704.50 | 0.8219 | 0.6639 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1032.00 | 1704.50 | 0.6055 | 0.2490 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 1250.00 | 814.29 | 1667.00 | 1704.50 | 0.9780 | 0.9587 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 1250.00 | 814.29 | 1928.00 | 1704.50 | 1.1311 | 1.2451 |